DGNS Relative Valuation - Diagnos Laboratorium Utama PT Tbk

Watchlist Manager

Watchlist

Price: 298 IDR -1.32%

Market Cap: Rp372.5B

Relative Value

The Relative Value of one DGNS stock under the Base Case scenario is 422.68 IDR. Compared to the current market price of 298 IDR, Diagnos Laboratorium Utama PT Tbk is Undervalued by 29%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

What is Relative Valuation?

How is Relative Value calculated?

DGNS Relative Value

Base Case

Undervaluation 29%

Relative Value

Price

Worst Case

Base Case

Best Case

Valuation Multiples

View Details

Multiples Across Competitors

All Multiples

P/S

P/E

EV/EBITDA

EV/EBIT

Forward Multiples

			Market Cap	P/S	P/E	EV/EBITDA	EV/EBIT
ID	D	Diagnos Laboratorium Utama PT Tbk IDX:DGNS	372.5B IDR	1.3	-195.7	-6 242.3	-6 242.3
US		CVS Health Corp NYSE:CVS	96.4B USD	0.2	54.5	13.9	13.9
US	C	Cigna Group XMUN:CGN	68.1B EUR	0.3	13.3	7.8	9.9
US		Cigna Corp NYSE:CI	70.7B USD	0.3	11.9	0	0
DE		Fresenius SE & Co KGaA XETRA:FRE	26.4B EUR	1.2	20.9	9.8	14.6
DE		Fresenius Medical Care AG XMUN:FME	23.3B EUR	1.2	23.8	9.1	16.9
US		Quest Diagnostics Inc NYSE:DGX	21.9B USD	2	22.2	12.2	16.5
US		Laboratory Corporation of America Holdings NYSE:LH	21.9B USD	1.6	25	12	17.4
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	11.2B EUR	0.6	11.5	5.4	10.1
US		Guardant Health Inc NASDAQ:GH	11.4B USD	11.6	-27.4	-29.9	-27.2
US		DaVita Inc NYSE:DVA	10.2B USD	0.7	13.6	7.1	9.6

				Revenue Growth	P/S to Growth
ID	D	Diagnos Laboratorium Utama PT Tbk IDX:DGNS	Average P/S: 1.9 1.3	N/A	N/A
US		CVS Health Corp NYSE:CVS	0.2	4%	0.1
US	C	Cigna Group XMUN:CGN	0.3	6%	0
US		Cigna Corp NYSE:CI	0.3	6%	0
DE		Fresenius SE & Co KGaA XETRA:FRE	1.2	5%	0.2
DE		Fresenius Medical Care AG XMUN:FME	1.2	3%	0.4
US		Quest Diagnostics Inc NYSE:DGX	2	5%	0.4
US		Laboratory Corporation of America Holdings NYSE:LH	1.6	6%	0.3
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	0.6	3%	0.2
US		Guardant Health Inc NASDAQ:GH	11.6	30%	0.4
US		DaVita Inc NYSE:DVA	0.7	4%	0.2

				Earnings Growth	PEG
ID	D	Diagnos Laboratorium Utama PT Tbk IDX:DGNS	Average P/E: 21.8 Negative Multiple: -195.7	N/A	N/A
US		CVS Health Corp NYSE:CVS	54.5	90%	0.6
US	C	Cigna Group XMUN:CGN	13.3	19%	0.7
US		Cigna Corp NYSE:CI	11.9	19%	0.6
DE		Fresenius SE & Co KGaA XETRA:FRE	20.9	26%	0.8
DE		Fresenius Medical Care AG XMUN:FME	23.8	16%	1.5
US		Quest Diagnostics Inc NYSE:DGX	22.2	12%	1.8
US		Laboratory Corporation of America Holdings NYSE:LH	25	27%	0.9
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	11.5	16%	0.7
US		Guardant Health Inc NASDAQ:GH	Negative Multiple: -27.4	N/A	N/A
US		DaVita Inc NYSE:DVA	13.6	21%	0.6

				EBITDA Growth	EV/EBITDA to Growth
ID	D	Diagnos Laboratorium Utama PT Tbk IDX:DGNS	Average EV/EBITDA: 9.7 Negative Multiple: -6 242.3	N/A	N/A
US		CVS Health Corp NYSE:CVS	13.9	28%	0.5
US	C	Cigna Group XMUN:CGN	7.8	4%	1.9
US		Cigna Corp NYSE:CI	Not Available	N/A	N/A
DE		Fresenius SE & Co KGaA XETRA:FRE	9.8	10%	1
DE		Fresenius Medical Care AG XMUN:FME	9.1	7%	1.3
US		Quest Diagnostics Inc NYSE:DGX	12.2	7%	1.7
US		Laboratory Corporation of America Holdings NYSE:LH	12	10%	1.2
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	5.4	7%	0.8
US		Guardant Health Inc NASDAQ:GH	Negative Multiple: -29.9	N/A	N/A
US		DaVita Inc NYSE:DVA	7.1	4%	1.8

				EBIT Growth	EV/EBIT to Growth
ID	D	Diagnos Laboratorium Utama PT Tbk IDX:DGNS	Average EV/EBIT: 13.6 Negative Multiple: -6 242.3	N/A	N/A
US		CVS Health Corp NYSE:CVS	13.9	22%	0.6
US	C	Cigna Group XMUN:CGN	9.9	6%	1.6
US		Cigna Corp NYSE:CI	Not Available	N/A	N/A
DE		Fresenius SE & Co KGaA XETRA:FRE	14.6	13%	1.1
DE		Fresenius Medical Care AG XMUN:FME	16.9	17%	1
US		Quest Diagnostics Inc NYSE:DGX	16.5	10%	1.6
US		Laboratory Corporation of America Holdings NYSE:LH	17.4	18%	1
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	10.1	17%	0.6
US		Guardant Health Inc NASDAQ:GH	Negative Multiple: -27.2	N/A	N/A
US		DaVita Inc NYSE:DVA	9.6	5%	1.9

Diagnos Laboratorium Utama PT Tbk
IDX:DGNS

Relative Value

Valuation Multiples

Multiples Across Competitors

DGNS Competitors Multiples
Diagnos Laboratorium Utama PT Tbk Competitors

See Also

Company

Help

Tools

Stocks

Diagnos Laboratorium Utama PT Tbk IDX:DGNS

Relative Value

Valuation Multiples

Multiples Across Competitors

DGNS Competitors Multiples Diagnos Laboratorium Utama PT Tbk Competitors

See Also

Company

Help

Tools

Stocks

Diagnos Laboratorium Utama PT Tbk
IDX:DGNS

DGNS Competitors Multiples
Diagnos Laboratorium Utama PT Tbk Competitors